Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Jul-19 4:15 PM View:  | Broadfin Healthcare Master ... 10% Owner | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 7,258,140 | -- | -- | (100%) 7.26M to 0 | |
| 18-Jul-19 7:48 PM View: | Raines Merilee Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 18,000 | -- | -- | (100%) 18.0K to 0 | |
| 18-Jul-19 7:40 PM View: | Barbarosh Craig A. Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 4,500 | -- | -- | (100%) 4.5K to 0 | |
| 18-Jul-19 7:53 PM View: | Tooman Craig A President and CEO Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 307,501 | -- | -- | (100%) 307.5K to 0 | |
| 18-Jul-19 7:36 PM View: | Ayres John C SEE REMARKS | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 129,889 | -- | -- | (100%) 129.89K to 0 | |
| 18-Jul-19 7:49 PM View: | Ready Christopher T VP of Sales and Marketing | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 53,728 | -- | -- | (100%) 53.73K to 0 | |
| 18-Jul-19 7:42 PM View: | Brinkley David L Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 18,000 | -- | -- | (100%) 18.0K to 0 | |
| 18-Jul-19 7:44 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 170,617 | -- | -- | (100%) 170.62K to 0 | |
| 18-Jul-19 7:46 PM View: | Hockaday Irvine O Jr Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 82,985 | -- | -- | (100%) 82.98K to 0 | |
| 18-Jul-19 7:50 PM View: | Robinson Lowell W Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 4,500 | -- | -- | (100%) 4.5K to 0 | |
| 18-Jul-19 7:54 PM View: | Vander Vort John Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 43,000 | -- | -- | (100%) 43.0K to 0 | |
| 18-Jul-19 7:45 PM View: | Hellums Rhonda Lynette CHIEF FINANCIAL OFFICER | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 51,424 | -- | -- | (100%) 51.42K to 0 | |
| 18-Jul-19 7:52 PM View: | Roche Robert P Jr Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 18,000 | -- | -- | (100%) 18.0K to 0 | |
| 18-Jul-19 7:56 PM View: | Yarno Wendy L Director | Aratana Therapeutics, Inc. (PETX) | 18-Jul-19 | Disposition | 18,000 | -- | -- | (100%) 18.0K to 0 | |
| 07-Jun-19 5:49 PM View: | Brinkley David L Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 33% 13.5K to 18.0K | |
| 07-Jun-19 5:53 PM View: | Hockaday Irvine O Jr Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 6% 78.48K to 82.98K | |
| 07-Jun-19 5:58 PM View: | Robinson Lowell W Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 100% 0 to 4.5K | |
| 07-Jun-19 6:03 PM View: | Vander Vort John Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 12% 38.5K to 43.0K | |
| 07-Jun-19 6:06 PM View: | Yarno Wendy L Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 33% 13.5K to 18.0K | |
| 07-Jun-19 6:01 PM View: | Roche Robert P Jr Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 33% 13.5K to 18.0K | |
| 07-Jun-19 5:55 PM View: | Raines Merilee Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 33% 13.5K to 18.0K | |
| 07-Jun-19 5:47 PM View: | Barbarosh Craig A. Director | Aratana Therapeutics, Inc. (PETX) | 06-Jun-19 | Grant | 4,500 | -- | -- | 100% 0 to 4.5K | |
| 05-Feb-19 5:48 PM View: | Hellums Rhonda Lynette CHIEF FINANCIAL OFFICER | Aratana Therapeutics, Inc. (PETX) | 01-Feb-19 | Grant | 24,923 | -- | -- | 94% 26.5K to 51.42K | |
| 01-Feb-19 5:45 PM View: | Ayres John C SEE REMARKS | Aratana Therapeutics, Inc. (PETX) | 30-Jan-19 | Market Sale (Planned) | 3,125 | $4.19 | $13,093.80 | (2%) 133.01K to 129.89K | (5%) |
| 28-Jan-19 5:41 PM View: | Ayres John C SEE REMARKS | Aratana Therapeutics, Inc. (PETX) | 24-Jan-19 | Grant | 34,923 | -- | -- | 36% 98.09K to 133.01K | |
| 28-Jan-19 5:46 PM View: | Ready Christopher T VP of Sales and Marketing | Aratana Therapeutics, Inc. (PETX) | 24-Jan-19 | Grant | 22,800 | -- | -- | 74% 30.93K to 53.73K | |
| 28-Jan-19 5:50 PM View: | Tooman Craig A President, CEO and CFO Director | Aratana Therapeutics, Inc. (PETX) | 24-Jan-19 | Payment of Exercise | 18,490 | $4.22 | $78,027.80 | (6%) 325.99K to 307.5K | (5%) |
| 28-Jan-19 5:43 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 24-Jan-19 | Grant | 34,923 | -- | -- | 26% 135.69K to 170.62K | |
| 28-Jan-19 5:50 PM View: | Tooman Craig A President, CEO and CFO Director | Aratana Therapeutics, Inc. (PETX) | 24-Jan-19 | Grant | 211,267 | -- | -- | 184% 114.72K to 325.99K | |
| 17-Dec-18 6:00 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 17-Dec-18 | Market Sale (Planned) | 46,094 | $5.85 | $269,788.00 | (7%) 649.72K to 603.62K | 24% |
| 09-Nov-18 6:00 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 07-Nov-18 | Market Sale (Planned) | 19,308 | $6.95 | $134,191.00 | (12%) 155.0K to 135.69K | 36% |
| 06-Nov-18 6:05 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 02-Nov-18 | Market Sale (Planned) | 692 | $6.95 | $4,809.40 | (< 1%) 155.69K to 155.0K | 36% |
| 31-Oct-18 6:00 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 30-Oct-18 | Market Sale (Planned) | 11,513 | $5.86 | $67,453.50 | (2%) 661.23K to 649.72K | 25% |
| 21-Sep-18 6:31 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 21-Sep-18 | Market Sale (Planned) | 75,000 | $6.06 | $454,305.00 | (10%) 736.23K to 661.23K | 27% |
| 14-Aug-18 5:32 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 14-Aug-18 | Market Sale (Planned) | 1,712 | $5.15 | $8,816.80 | (1%) 157.41K to 155.69K | 14% |
| 14-Aug-18 5:32 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 13-Aug-18 | Market Sale (Planned) | 8,660 | $5.15 | $44,599.00 | (5%) 166.07K to 157.41K | 14% |
| 10-Aug-18 5:45 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 10-Aug-18 | Market Sale (Planned) | 1,954 | $5.15 | $10,063.10 | (1%) 168.02K to 166.07K | 14% |
| 10-Aug-18 5:45 PM View: | Heinen Ernst Chief Development Officer | Aratana Therapeutics, Inc. (PETX) | 08-Aug-18 | Market Sale (Planned) | 2,674 | $5.15 | $13,771.10 | (2%) 170.69K to 168.02K | 14% |
| 30-Jul-18 5:51 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 30-Jul-18 | Market Sale (Planned) | 11,513 | $4.33 | $49,842.10 | (2%) 747.74K to 736.23K | (2%) |
| 30-Jul-18 5:38 PM View: | Brege Laura Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 50% 9.0K to 13.5K | |
| 30-Jul-18 5:54 PM View: | Vander Vort John Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 13% 34.0K to 38.5K | |
| 30-Jul-18 5:58 PM View: | Yarno Wendy L Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 50% 9.0K to 13.5K | |
| 30-Jul-18 5:48 PM View: | Roche Robert P Jr Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 50% 9.0K to 13.5K | |
| 30-Jul-18 5:45 PM View: | Raines Merilee Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 50% 9.0K to 13.5K | |
| 30-Jul-18 5:40 PM View: | Brinkley David L Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 50% 9.0K to 13.5K | |
| 30-Jul-18 5:43 PM View: | Hockaday Irvine O Jr Director | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 6% 73.98K to 78.48K | |
| 27-Jun-18 5:32 PM View: | Standridge Brent Chief Operating Officer | Aratana Therapeutics, Inc. (PETX) | 25-Jun-18 | Market Sale (Planned) | 10,000 | $4.56 | $45,644.00 | (9%) 109.97K to 99.97K | 3% |
| 30-Apr-18 5:49 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 30-Apr-18 | Market Sale (Planned) | 11,513 | $5.00 | $57,582.30 | 2% 736.23K to 747.74K | (12%) |
| 01-Feb-18 5:29 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 30-Jan-18 | Market Sale (Planned) | 19,367 | $4.77 | $92,301.20 | (2%) 778.62K to 759.26K | 7% |
| 26-Jan-18 5:32 PM View: | St Peter Steven PRESIDENT AND CEO Director | Aratana Therapeutics, Inc. (PETX) | 25-Jan-18 | Grant | 135,600 | -- | -- | 21% 643.02K to 778.62K |
